JRKL-AS1
gene geneOn this page
Summary
JRKL-AS1 (JRKL antisense RNA 1, HGNC:43670) is a long non-coding RNA gene on chromosome 11q21.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43670 |
| Approved symbol | JRKL-AS1 |
| Name | JRKL antisense RNA 1 |
| Location | 11q21 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000255679 |
| Ensembl biotype | lncRNA |
| Entrez | 100874053 |
| RNAcentral | URS0000D5A512 — lncRNA, 648 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 lncRNA
ENST00000511243, ENST00000835074, ENST00000835075, ENST00000835076, ENST00000835077, ENST00000835078, ENST00000835079, ENST00000835080
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000511243 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002087711 | 96449932 | 96450033 |
| ENSE00002211478 | 96506729 | 96506826 |
| ENSE00002232344 | 96447132 | 96447243 |
| ENSE00002268995 | 96447349 | 96447462 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 87.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0094 / max 4.9619, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121923 | 0.0094 | 6 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.32 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.39 | gold quality |
| ventricular zone | UBERON:0003053 | 69.21 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 69.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 69.11 | gold quality |
| left testis | UBERON:0004533 | 68.39 | gold quality |
| testis | UBERON:0000473 | 67.99 | gold quality |
| right testis | UBERON:0004534 | 67.76 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 66.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 66.23 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.17 | gold quality |
| muscle tissue | UBERON:0002385 | 64.89 | gold quality |
| sural nerve | UBERON:0015488 | 64.43 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 62.06 | gold quality |
| muscle of leg | UBERON:0001383 | 60.93 | gold quality |
| bone marrow | UBERON:0002371 | 59.90 | gold quality |
| gastrocnemius | UBERON:0001388 | 59.63 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 59.34 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.07 | gold quality |
| vermiform appendix | UBERON:0001154 | 58.76 | gold quality |
| primary visual cortex | UBERON:0002436 | 58.46 | gold quality |
| endometrium | UBERON:0001295 | 58.44 | gold quality |
| lymph node | UBERON:0000029 | 57.84 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 57.64 | gold quality |
| calcaneal tendon | UBERON:0003701 | 57.56 | gold quality |
| islet of Langerhans | UBERON:0000006 | 57.37 | gold quality |
| monocyte | CL:0000576 | 57.33 | gold quality |
| brain | UBERON:0000955 | 57.00 | gold quality |
| gall bladder | UBERON:0002110 | 56.78 | gold quality |
| urinary bladder | UBERON:0001255 | 56.63 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.